Reinhardt W, Luster M, Rudorff K H, Heckmann C, Petrasch S, Lederbogen S, Haase R, Saller B, Reiners C, Reinwein D, Mann K
Department of Medicine, University of Essen, Germany.
Eur J Endocrinol. 1998 Jul;139(1):23-8. doi: 10.1530/eje.0.1390023.
Several studies have suggested that iodine may influence thyroid hormone status, and perhaps antibody production, in patients with autoimmune thyroid disease. To date, studies have been carried out using large amounts of iodine. Therefore, we evaluated the effect of small doses of iodine on thyroid function and thyroid antibody levels in euthyroid patients with Hashimoto's thyroiditis who were living in an area of mild dietary iodine deficiency.
Forty patients who tested positive for anti-thyroid (TPO) antibodies or with a moderate to severe hypoechogenic pattern on ultrasound received 250 microg potassium iodide daily for 4 months (range 2-13 months). An additional 43 patients positive for TPO antibodies or with hypoechogenicity on ultrasound served as a control group. All patients were TBII negative.
Seven patients in the iodine-treated group developed subclinical hypothyroidism and one patient became hypothyroid. Three of the seven who were subclinically hypothyroid became euthyroid again when iodine treatment was stopped. One patient developed hyperthyroidism with a concomitant increase in TBII titre to 17 U/l, but after iodine withdrawal this patient became euthyroid again. Only one patient in the control group developed subclinical hypothyroidism during the same time period. All nine patients who developed thyroid dysfunction had reduced echogenicity on ultrasound. Four of the eight patients who developed subclinical hypothyroidism had TSH concentrations greater than 3 mU/l. In 32 patients in the iodine-treated group and 42 in the control group, no significant changes in thyroid function, antibody titres or thyroid volume were observed.
Small amounts of supplementary iodine (250 microg) cause slight but significant changes in thyroid hormone function in predisposed individuals.
多项研究表明,碘可能会影响自身免疫性甲状腺疾病患者的甲状腺激素状态,或许还会影响抗体产生。迄今为止,相关研究均使用的是大剂量碘。因此,我们评估了小剂量碘对居住在轻度膳食碘缺乏地区、患有桥本甲状腺炎的甲状腺功能正常患者的甲状腺功能及甲状腺抗体水平的影响。
40例抗甲状腺(TPO)抗体检测呈阳性或超声显示中度至重度低回声模式的患者,每日服用250微克碘化钾,持续4个月(范围为2 - 13个月)。另外43例TPO抗体检测呈阳性或超声显示低回声的患者作为对照组。所有患者TBII均为阴性。
碘治疗组中有7例患者出现亚临床甲状腺功能减退,1例患者出现甲状腺功能减退。7例亚临床甲状腺功能减退患者中有3例在停止碘治疗后再次恢复甲状腺功能正常。1例患者出现甲状腺功能亢进,同时TBII滴度升至17 U/l,但碘停用后该患者再次恢复甲状腺功能正常。同期对照组中只有1例患者出现亚临床甲状腺功能减退。所有9例出现甲状腺功能障碍的患者超声显示回声均降低。8例出现亚临床甲状腺功能减退的患者中有4例TSH浓度大于3 mU/l。碘治疗组的32例患者和对照组的42例患者,甲状腺功能、抗体滴度或甲状腺体积均未观察到显著变化。
少量补充碘(250微克)会使易感个体的甲状腺激素功能发生轻微但显著的变化。